|
2011
|
Invention
|
Compositions comprising trypsin-cleavable amphetamine prodrugs and inhibitors thereof. Pharmaceut... |
|
2010
|
Invention
|
Compositions comprising enzyme-cleavable phenol-modified tapentadol prodrug. A method of providin... |
|
2009
|
Invention
|
Pharmaceutical compositions with attenuated release of phenolic opioids. Pharmaceutical compositi... |
|
|
Invention
|
Analogs of propofol, preparation thereof and use as anesthetics. Compounds of formula (I) wherein... |
|
|
Invention
|
Anesthetic compounds. The invention provides novel phenolic ester local anesthetic compounds. The... |
|
2008
|
Invention
|
Peripheral phenolic opioid antagonist. N-Methyldiprenorphine, useful as an opioid antagonist. |
|
|
Invention
|
Stereoisomers propofol therapeutic compounds. A (-)-stereoisomer of formula (I): wherein X is H o... |
|
|
Invention
|
Therapeutic compounds. A (-)-stereoisomer of formula (I): (formula I), wherein X is H or F; or a ... |
|
|
Invention
|
Pro-drugs of peripheral phenolic opioid antagonists. Compounds of formula (I), in which X, Y, R1,... |
|
|
Invention
|
N-17-alkylated prodrugs of opioids. Compounds of formula (II) R1R2R3N+-(C(R1a)(R2a))-Ar-Z-C(O)-Y-... |
|
2007
|
Invention
|
Anesthetic compounds. In one embodiment the invention provides novel compounds of Formula (I) as ... |
|
|
Invention
|
Controlled release of phenolic opioids. A method of providing a patient with controlled release o... |
|
2006
|
Invention
|
Prodrugs of active agents. Disclosed herein are prodrugs of active agents which contain at least ... |
|
2005
|
Invention
|
Compositions of nicotinic agonists and therapeutic agents and methods for treating or preventing ... |
|
|
Invention
|
Compositions and methods for treating or preventing pain.
Disclosed herein are compositions and ... |
|
|
Invention
|
Compositions and methods for treating or preventing pain. Disclosed herein are compositions and m... |
